Appelhans Dannielle
CEO and President at Rubius Therapeutics, Inc.
- Sold, on record
- $7k
- Dollars the filings state
- Form 4 sales
- 3
- Latest Feb 24, 2023
- Form 144 notices
- 0
- Proposed sales
- Companies
- 1
- Filed as an executive or holder
Companies
- Rubius Therapeutics, Inc.CEO and President
Sales by reason
0
Routine
0
Plan not stated
0
No plan
3
Unusual
Form 4 sales per year, every sale on record.
Timeline
- 1 Form 4 sale Rubius Therapeutics, Inc.UnusualAug 10, 2022 2022
Sold 5,737 shares at $0.80 ($5k)
Appelhans Dannielle, Chief Operating Officer
Sold 45.9% of holdings ($10k position)6,763 shares leftFirst sale on recordFiling
- 2 Form 4 sale Rubius Therapeutics, Inc.UnusualFeb 1, 2023 +175 days
Sold 3,878 shares at $0.25 ($970)
Appelhans Dannielle, CEO and President
Sold 27.2% of holdings ($4k position)10,385 shares leftFiling
- 3 Form 4 sale Rubius Therapeutics, Inc.UnusualFeb 24, 2023 +23 days
Sold 10,385 shares at $0.13 ($1k)
Appelhans Dannielle, CEO and President
Sold 100% of holdings ($1k position)0 shares leftFiling
Every transaction
Loading transactions…
Sales and notices (3)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Feb 24, 2023 | Feb 27, 2023 | Rubius Therapeutics, Inc. | CEO and President | Form 4 sale | 10,385 | $1k | 100.0% | Unusual | SEC |
| Feb 1, 2023 | Feb 1, 2023 | Rubius Therapeutics, Inc. | CEO and President | Form 4 sale | 3,878 | $970 | 27.2% | Unusual | SEC |
| Aug 10, 2022 | Aug 12, 2022 | Rubius Therapeutics, Inc. | Chief Operating Officer | Form 4 sale | 5,737 | $5k | 45.9% | Unusual | SEC |